NCT01596270View on ClinicalTrials.gov

A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2012

Primary Completion Date

October 31, 2014

Study Completion Date

October 31, 2014

Conditions
Neoplasm Malignant
Interventions
DRUG

SAR245409

Pharmaceutical form: tablet Route of administration: oral

Trial Locations (3)

48201

Investigational Site Number 840001, Detroit

75230

Investigational Site Number 840003, Dallas

08903

Investigational Site Number 840002, New Brunswick

Sponsors

Lead Sponsor

Sanofi
All Listed Sponsors
lead

Sanofi

INDUSTRY

NCT01596270 - A Study of the Safety and Pharmacokinetics of SAR245409 Tablets in Patients With Solid Tumors or Lymphoma | Biotech Hunter | Biotech Hunter